Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Sep 10, 2021 10:55am
80 Views
Post# 33839653

RE:RE:RE:RE:RE:RE:BNN Market Call

RE:RE:RE:RE:RE:RE:BNN Market Call
MrMugsy wrote:
Chianchin wrote: The base is GUD MNGT frantic buyback so that the share price does not deep below $5 and to $3.90. Only a matter of time to $3.90 and more so faster if GUD MNGT does one more disastrous acquisition


Chi-Chi ... there are no frantic buybacks.  That's poppy-kok.
Not sure how you got to $3.90 but if you can make it happen, I'll free up the cash for it.

Disastorous acquisition ????  Have you seen revenue growth over the past few years or are you not paying attention to the metrics that matter ? man-o-man

And "yes" ... we have had retail shareholder churn - since the company has been in existance.  That is expected as many don't know what they are buying here.  It's just part of the game. 

You can't control it - so find a way to enjoy it !!!  Cheers to the future !!!



Look who's talking, the peddler of lies himself. How is Synergy doing? What about Anitbe? QPT? What about ONTX? Care to post your massive losses (and the company's) losses on those? What do all those have in common? They all have reverse split and are down over 90% and you pumped them all the way down. This is what you have peddled here. 

Retail churn will not harm the share price as a few thousand shares here/there are sold. You are witnessing selling from major holders, those with hundreds of thousands of shares that take months to liquidate. This can take years. Shareholders base is changing no matter how many lies you post on here of 'strong hands'. No mutual fund wants a turd like this on it's books showing losses of 40-50% while the market reaches all time highs. Only ones buying here are the 'value' people and as soon as they see they are in a trap with underperforming failing management the selling will continue. This is why this turd can't get going. 
<< Previous
Bullboard Posts
Next >>